These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 9233801)

  • 1. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH; Derynck R
    EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
    Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
    J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
    Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H
    J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
    Zhu HJ; Sizeland AM
    J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
    Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
    J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
    Luo K; Lodish HF
    EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basolateral delivery of the type I transforming growth factor beta receptor is mediated by a dominant-acting cytoplasmic motif.
    Yin X; Kang JH; Andrianifahanana M; Wang Y; Jung MY; Hernandez DM; Leof EB
    Mol Biol Cell; 2017 Oct; 28(20):2701-2711. PubMed ID: 28768825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.
    Muramatsu M; Yan J; Eto K; Tomoda T; Yamada R; Arai K
    Mol Biol Cell; 1997 Mar; 8(3):469-80. PubMed ID: 9188099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T; Moustakas A; Lin HY; Lodish HF
    Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
    Wang T; Danielson PD; Li BY; Shah PC; Kim SD; Donahoe PK
    Science; 1996 Feb; 271(5252):1120-2. PubMed ID: 8599089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
    Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of transforming growth factor-beta receptors in rat kidney development.
    Choi ME; Liu A; Ballermann BJ
    Am J Physiol; 1997 Sep; 273(3 Pt 2):F386-95. PubMed ID: 9321911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of type I receptors for transforming growth factor-beta and activin.
    ten Dijke P; Yamashita H; Ichijo H; Franzén P; Laiho M; Miyazono K; Heldin CH
    Science; 1994 Apr; 264(5155):101-4. PubMed ID: 8140412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.
    Attisano L; Cárcamo J; Ventura F; Weis FM; Massagué J; Wrana JL
    Cell; 1993 Nov; 75(4):671-80. PubMed ID: 8242742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
    Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
    J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
    Doré JJ; Edens M; Garamszegi N; Leof EB
    J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
    Tazat K; Hector-Greene M; Blobe GC; Henis YI
    Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.